Great news! The FDA updated testosterone product labels today. The TRAVERSE trial found no increased CV risk, so the boxed warning is planned to be removed! However, a blood pressure warning has been added after ABPM studies. Use remains limited to men with medical conditions causing low T.
The March 2024 issue of @JUrology is out TODAY!!!! 📚🗞️Not only is the content 💯🔥, but the cover is perfection, thanks to the incredible illustration from @onlyoscarli - thank you for this amazing contribution! The cover depicts an impactful article from @LoebStacy et al.
Announcement to the future urologists out there. Check out ✅ this rare opportunity to join @NYUUrology@NYUUROresidency for learning, operating, and making colleagues in a great location. @AmerUrological@UroAcademic 🗽💫😷
Due to unforeseen circumstances, we are seeking US board-eligible, candidates for a one yr urologic oncology clinical fellowship at @NYUUrology. Best place to become beyond proficient in robotic oncology, #prostatecancer focal therapy, and multi-d care. DM me if interested.
An honor and pleasure having @tanejauro sharing knowledge on the evolution and revolution on prostate cancer diagnosis and @drhelenbernie on TRT after prostate cancer diagnosis on the Dr.Geo podcast. Wow! Thank you! 👊🏼🙏🏼💪🏼
Excited to present our poster of the IMPLEMENT study on barriers to and facilitators of first-line treatment intensification in mCSPC -poster K12 #GU24 https://t.co/2IpZJ7w8Cv
Yoga seems to be good for endothelial function. Effect of Yoga on Endothelial Function: A Systematic Review and Meta-Analysis | Journal of Integrative and Complementary Medicine https://t.co/7CVMtJ0mAV